Pediatric Cardiology

, Volume 30, Issue 5, pp 690–698

Multipotent Progenitor Cells in Regenerative Cardiovascular Medicine

  • Jason T. Lam
  • Alessandra Moretti
  • Karl-Ludwig Laugwitz
Riley Symposium

DOI: 10.1007/s00246-009-9450-1

Cite this article as:
Lam, J.T., Moretti, A. & Laugwitz, KL. Pediatr Cardiol (2009) 30: 690. doi:10.1007/s00246-009-9450-1

Abstract

Regenerative therapies for heart diseases require the understanding of the molecular mechanisms that govern the fates and differentiation of the diverse muscle and nonmuscle cell lineages that form during heart development. During mouse cardiogenesis, the major lineages of the mature heart, cardiomyocytes, smooth muscle, endothelial cells, and cardiac mesenchyme, arise from multipotent cardiovascular progenitors expressing the transcription factors Mesp1, Isl1, Nkx2-5, and Tbx18. Recent identification of stem/progenitor cells of embryonic origin with intrinsic competence to differentiate into multiple lineages of the heart offers exciting new possibilities for cardiac regeneration. When combined with new advances in nuclear reprogramming, the prospect of achieving autologous, cardiomyogenic, stem-cell-based therapy might be within reach.

Keywords

Cardiovascular progenitors Cardiogenesis Nuclear reprogramming Induced pluriopotent stem (iPS) cells 

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Jason T. Lam
    • 1
  • Alessandra Moretti
    • 1
  • Karl-Ludwig Laugwitz
    • 1
  1. 1.Klinikum rechts der Isar and German Heart CenterTechnical University of MunichMunichGermany

Personalised recommendations